Indeno[1,2-c]isoquinolines as enhancing agents on all-trans retinoic acid-mediated differentiation of human myeloid leukemia cells

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 3, 2008, Pages 1125-1132

  Kim, Seung Hyun ^a   Oh, Sang Mi ^b   Song, Ju Han ^a   Cho, Daeho ^c   Le, Quynh Manh ^b   Lee, Suh Hee ^b   Cho, Won Jea ^b   Kim, Tae Sung ^a  

^a Korea University   (South Korea)

^b Chonnam National University   (South Korea)

^c Sookmyung Women's University   (South Korea)

Author keywords

All trans retinoic acid; Differentiation; Indenoisoquinoline; Leukemia

Indexed keywords

11 HEXYL 11 HYDROXY 6 (4 METHOXYBENZYL) 6H,11H INDENO[1,2-C]ISOQUINOLIN 5 ONE; 11 HEXYL 6 (4 METHOXYBENZYL) 6H,11H INDENO[1,2 C]ISOQUINOLIN 5 ONE; 11 HYDROXY 6 (4 METHOXYBENZYL) 11 METHYL 6H,11H INDENO[1,2 C]ISOQUINOLIN 5 ONE; 6 (4 METHOXYBENZYL) 6H INDENO[1,2 C]ISOQUINOLIN 5,11 DIONE; ISOQUINOLINE DERIVATIVE; RETINOIC ACID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOID LEUKEMIA; PROMYELOCYTIC LEUKEMIA; TREATMENT OUTCOME;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; INDENES; ISOQUINOLINES; LEUKEMIA, MYELOID; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; TRETINOIN;

EID: 38849090062     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.10.086     Document Type: Article

References (26)

1. Beere H.M., and Hickman J.A. Anti-Cancer Drug Des. 8 (1993) 299
2. Breitman T.R., Selonick S.E., and Collins S.J. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 2936
3. Chomienne C., Balitrand N., Cost H., Degos L., and Abita J.P. Leuk Res. 10 (1986) 1301
4. Degos L., and Wang Z.Y. Oncogene 20 (2001) 7140
5. Frankel S.R., Eardley A., Lauwers G., Weiss M., and Warrell Jr. R.P. Ann. Intern. Med. 17 (1992) 292
6. Hershberger P.A., Yu W.D., Modzelewski R.A., Rueger R.M., Johnson C.S., and Trump D.L. Clin. Cancer Res. 7 (2001) 1043
7. Sokoloski J.A., Shyam K., and Sartorelli A.C. Oncol. Res. 9 (1997) 31
8. Kang S.N., Lee M.H., Kim K.M., Cho D., and Kim T.S. Biochem. Pharmacol. 61 (2001) 1487
9. Kohlhagen G., Paull K., Cshman M., Nagafuji P., and Pommier Y. Mol. Pharmacol. 54 (1998) 50
10. Staker B.L., Hjerrild K., Feese M.D., Behnke C.A., Burgin Jr. A.B., and Stewart L. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 15387
11. Ling Y.H., Tseng M.T., and Nelson J.A. Differentiation 46 (1991) 135
12. Aller P., Rius C., Mata F., Zorrilla A., Cabanas C., Bellon T., and Bernabeu C. Cancer Res. 52 (1992) 1245
13. Cho W.-J., Le Q.M., Van H.T.M., Lee K.Y., Kang B.Y., Lee E.-S., Lee S.K., and Kwon Y. Bioorg. Med. Chem. Lett. 17 (2007) 3531
14. Van H.T.M., Le Q.M., Lee E.-S., Kwon Y., Kim T.S., Le T.N., Lee S.-H., and Cho W.-J. Bioorg. Med. Chem. Lett. 17 (2007) 5763
15. Tanaka H., Abe E., Miyaura C., Shiina Y., and Suda T. Biochem. Biophy. Res. Commun. 117 (1983) 86
16. Kansas G.S., Muirhead M.J., and Dailey M.O. Blood 76 (1990) 2483
17. Pan Q., Granger J., O'Connell T.D., Somerman M.J., and Simpson R.U. Biochem. Pharmacol. 54 (1997) 909
18. Song X., Bishop J.E., Okamura W.H., and Norman A.W. Endocrinology 139 (1998) 457
19. Marcinkowska E. Anticancer Res. 499 (2001)
20. Breitman T.R., and He R.Y. Cancer Res. 50 (1990) 6268
21. Noguchi T., Shinji C., Kobayashi H., Makishima M., Miyachi H., and Hashimoto Y. Biol. Pharm. Bull. 28 (2005) 563
22. Norman A.W., Okamura W.H., Hammond M.W., Bishop J.E., Dormanen M.C., Bouillon R., van Baelen H., Ridall A.L., Daane E., Khoury R., and Farach-Carson M.C. Mol. Endocrinol. 11 (1997) 1518
23. Zanello L.P., and Norman A.W. J. Biol. Chem. 272 (1997) 22617
24. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., Dominguez C.E., and Jurutka P.W. J. Bone Miner. Res. 13 (1998) 325
25. Kim T.S., Kang B.Y., Lee M.H., Choe Y.K., and Hwang S.Y. Br. J. Pharmacol. 134 (2001) 571
26. Collins S.J., Ruscetti F.W., Gallagher R.E., and Gallo R.C. J. Exp. Med. 149 (1979) 969